WHERE: Henry B. Gonzalez Convention Center, San Antonio, Texas
Advertisement
SAN ANTONIO, Feb. 26 /PRNewswire-USNewswire/ -- The International Stroke Conference features more than 900 presentations on stroke science, and more than 3,500 attendees are expected. The American Stroke Association communications department offers a full program of news materials and news events to media. Conference highlights are below.
Advertisement
The conference is from Wednesday, Feb. 24 - Friday, Feb. 26, 2010.
For complete coverage, visit the American Heart Association/American Stroke Association's online news room at americanheart.mediaroom.com and click on Scientific Conferences & Meetings.
Friday News from the International Stroke Conference:
NEWS CONFERENCE:
Late breaking stroke science
This session of stroke science highlights just-completed trials - three on stroke prevention and one on stroke rehabilitation.
NEWS RELEASES:
Downloadable audio interviews with American Stroke Association spokespeople offering perspective on each of the news releases are available. Listen here
NEWS TIPS:
-- The CSPS II trial is a multi-center, double-blind study that found the drug cilostazol was comparable to aspirin in preventing recurrent strokes, and patients taking cilostazol were less likely to develop brain bleeding. -- A subanalysis of the RE-LY trial found that the anti-clotting drug dabigatran etexilate worked just as well as warfarin to prevent strokes, and caused less bleeding than warfarin in patients with atrial fibrillation. -- A rehabilitation study finds human- or robot-assisted therapy improved post-stroke arm movement better than usual care, even several years after a stroke. -- The CREST trial stenting in the neck arteries and surgery to remove plaque buildup in neck arteries proved similar in overall long-term safety and efficacy, but showed differences in stroke and heart attack in the weeks following the procedure. -- News conference video and a written summary are available at americanheart.mediaroom.com.
SOURCE American Heart Association
